Ketamine for the treatment of menstrually related symptoms
OwnerPhilip E. WOLFSONinventor
Life of this patent
Estimating the term…
Abstract
The present invention features methods, compositions, and kits for the treatment of all forms of emotional and painful symptoms related to the menstrual cycle, including symptoms characteristic of menstrual cycle-related disorders, such as premenstrual dysphoric disorder (PMDD), premenstrual syndrome (PMS), menopause, perimenopause, and sub-diagnostic emotional, psychological, cognitive, spiritual, and/or physical symptoms of the menstrual cycle.
Claims12
A method of ameliorating symptoms in a subject suffering from premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD) arising from the subject's menstrual cycle, the method comprising administering to the subject one or more doses of 25 mg, 50 mg, or 100 mg ketamine, or a pharmaceutically acceptable salt thereof, to ameliorate the symptoms,
- wherein (i) the ketamine, or a pharmaceutically acceptable salt thereof, is administered daily or intermittently in response to the severity of the symptoms during the subject's menstrual cycle, and (ii) there is a period of at least one week during which no ketamine is administered to the subject during the subject's menstrual cycle.
Dependencies are inferred from the claim text.